Journal
CLINICAL RESEARCH IN CARDIOLOGY
Volume 103, Issue 3, Pages 229-235Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00392-013-0642-6
Keywords
Placebo adherence; Cardiovascular mortality; Meta-analysis
Categories
Ask authors/readers for more resources
We aim to demonstrate the effect of placebo adherence on reducing CV mortality. Good adherence, whether to drug or placebo treatment, is associated with lower CV mortality. However, current evidence for the positive effect of placebo adherence on reducing CV mortality is relatively weak. We conducted a fixed-effect meta-analysis of eight randomized clinical trials to evaluate the effect of placebo adherence on reducing CV mortality. We made a comparison between good placebo adherence and poor drug adherence. Compared with poor adherence to drug treatment, good adherence to placebo treatment was associated with lower CV mortality (OR = 0.68, 95 % CI 0.60-0.77). Good adherence to placebo has a positive effect on reducing CV mortality. The effect of adherence on reducing CV mortality may be independent of the drug effect.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available